Skip to main content

Table 1 Demographic and clinical characteristics

From: Metastasis to lateral lymph nodes with no mesenteric lymph node involvement in low rectal cancer: a retrospective case series

 

Entire sample (n = 42)

meso+, lat+ (n = 26)

meso+, lat− (n = 4)

meso−, lat+ (n = 5)

meso−, lat− (n = 7)

Age (years), mean ± SD

58.79 ± 10.69

58.23 ± 11.14

64.75 ± 12.09

58.80 ± 6.53

57.43 ± 11.66

Male sex, n (%)

24 (57.1)

16 (61.5)

2 (50.0)

2 (40.0)

4 (57.1)

BMI (kg/m2), mean ± SD

24.61 ± 3.37

24.48 ± 3.37

24.52 ± 5.32

25.56 ± 3.56

24.64 ± 2.72

Distance from AV (cm), median (range)

4.8 (0–8)

4.55 (0–8)

5.65 (1–8)

4.8 (3–5.5)

5.6 (3.5–8)

cT Stage, n (%)

 ct2

2 (4.8)

   

1 (14.3)

 cT3

31 (73.8)

21 (80.8)

3 (75.0)

4 (80.0)

4 (57.1)

 cT4

9 (21.4)

5 (19.2)

1 (25.0)

1 (20.0)

2 (28.6)

cN Stage, n (%)

 cN1

21 (50.0)

10 (38.5)

1 (25)

5 (100)

4 (57.1)

 cN2

21 (50.0)

16 (61.5)

3 (75)

 

3 (42.9)

nCRT, n (%)

16 (38.1)

10 (38.5)

1 (25.0)

2 (40)

3 (42.9)

  1. AV anal verge, BMI body mass index, lat lateral lymph nodes, meso mesenteric lymph nodes